Commentary · 29 Mar 2023
Conference abstractPublished 6 Oct 2014
Skin immunization against rotavirus using microneedles
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Despite progress in the prevention of rotavirus following the introduction of rotavirus vaccines in middle income and developed countries, diarrheal disease remains a major killer among children in low-income countries of Africa and Asia. The lower efficacy of live oral vaccines, the need for a separate supply chain with large volume of cold storage, and the perceived concern about adverse events (e.g., intussusception) all point to the need for a second generation of parenteral vaccine. In our early studies, we demonstrated high immunogenicity and protective efficacy of an inactivated rotavirus vaccine (IRV) when formulated with aluminum adjuvant and administered intramuscularly (IM) in mice and gnotobiotic piglets. We recently assessed new technology to deliver rotavirus vaccine and demonstrated dose sparing and enhanced immunogenicity of IRV without adjuvant administered intradermally (ID) using a microneedle patch in mice. In the present study, we further assessed whether IRV without adjuvant when administered ID using a microneedle device MicronJet600® could induce protective immunity and confer protection in comparison with aluminum-adjuvanted IM-administered IRV in neonatal gnotobiotic piglets. Three doses of 5 μg IRV when administered by ID and 5 μg IRV formulated with 600 μg Al(OH)3 when administered by IM induced comparable IgG, IgA, and neutralizing titers in serum of piglets. Both IRV immunization regimens protected piglets from oral challenge with a virulent human RV Wa strain, as evidenced by reduction in or lack of rotavirus antigen shedding in stool and lower mean diarrhea scores. By contrast, placebo-vaccinated piglets shed rotavirus antigen for up to 7 days or developed diarrhea. These findings demonstrate the immunogenicity and protective efficacy of IRV in a large animal model and further help establish the proof of concept for IM and ID immunization against rotavirus.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract
Nanoparticle-infused-biodegradable-microneedle technology for skin cancer treatment
Conference abstract · 20 Sep 2018
Enhanced immunity in intradermal vaccination by novel hollow microneedles
Conference abstract · 2017
Transcutaneous immunization via rapidly dissolvable microneedles protects against hand-foot-and-mouth disease caused by Enterovirus 71
Research article · 30 Sep 2010
Psoriasis is an immune system disorder identified as a skin disease: A Survey
More from this journal
The newest in Journal of Antivirals & Antiretrovirals.
Conference abstract · 23 Jun 2025
How is really working adaptive immune system in mammals? A novel conception and reverse pathway theory, which will bring novel multibillion super-antibody (sab) technology for curing of all of infectious diseases and cancer!
Conference abstract · 23 Jun 2025
Exploring signature proteins to design a novel multi-epitope vaccine candidate against Mycobacterium tuberculosis: An in-silico approach
Conference abstract · 23 Jun 2025
Correlation Between the Rh/ABO system and infection due to sars cov2 in morocco
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Antivirals & Antiretrovirals
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Baoming Jiang”

